Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript August 4, 2025
Axsome Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.92, expectations were $-1.
Operator: Good morning, and welcome to the Axsome Therapeutics Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this call is being recorded. I would now like to turn the call over to Darren Opland, Director of Corporate Communications at Axsome Therapeutics....
